Molbio Diagnostics made a strong market debut, with shares listing over 21% above the issue price on both the BSE and NSE, valuing the company at more than Rs 10,875 crore. The IPO, subscribed 70.26 times, will fund R&D infrastructure and capacity expansion across its Goa and Visakhapatnam manufacturing units.